ibaraki
viru
ibav
one
strain
epizoot
hemorrhag
diseas
viru
ehdv
serotyp
member
genu
orbiviru
reovirida
famili
known
caus
agent
ibaraki
diseas
character
paralysi
swallow
muscl
although
effect
vaccin
wide
use
recent
reemerg
ibaraki
diseas
combin
cocircul
ehdv
rais
alert
level
epidem
ibaraki
diseas
addit
orbiviru
famili
contain
mani
virus
caus
sever
loss
livestock
industri
therefor
import
understand
detail
molecular
mechan
infect
viru
infect
initi
releas
viral
genom
intracellular
compart
target
cell
sever
mechan
known
genom
releas
cytoplasm
one
well
known
mechan
direct
fusion
mechan
util
sever
envelop
virus
human
immunodefici
mous
hepat
viru
paramyxovirus
envelop
virus
also
known
use
host
endosom
pathway
facilit
infect
reoviru
famili
envelop
infect
host
cell
believ
occur
via
host
endosom
pathway
attach
cell
surfac
host
endosom
pathway
incorpor
particl
along
endosom
matur
dissoci
outermost
capsid
protein
proteolyt
cleavag
viral
protein
occur
especi
proteolyt
cleavag
endosom
proteas
cathepsin
b
l
essenti
process
infect
word
express
level
proteas
affect
suscept
host
cell
viru
infect
addit
endosom
proteas
extracellular
proteas
also
play
import
role
promot
certain
reoviru
infect
vivo
shown
tissu
specif
proteas
contribut
definit
target
organ
rotaviru
infect
hand
critic
condit
activ
orbiviru
infect
remain
unidentifi
although
suggest
orbiviru
also
util
host
endosom
pathway
involv
proteas
report
studi
envelop
virus
shown
virus
util
endosom
pathway
two
differ
way
virus
influenza
viru
use
low
ph
environ
virus
sever
acut
respiratori
syndrom
viru
use
endosom
proteas
rather
low
ph
environ
clarifi
mechan
use
orbiviru
test
effect
environment
ph
orbiviru
infect
use
ibav
util
endosom
pathway
ibav
infect
confirm
use
endosom
inhibitor
hamster
lung
cell
infect
ibav
presenc
three
differ
endosom
inhibitor
bafilomycin
baf
sigma
st
loui
mo
usa
chlorpromazin
cpz
abcam
cambridg
uk
dynasor
wako
osaka
japan
drug
inhibit
clathrin
depend
endocytosi
differ
manner
baf
antibiot
deriv
streptomyc
griseu
specif
inhibit
vacuolar
type
h
atpas
cpz
disloc
clathrin
adaptor
protein
plasma
membran
cytosol
dynasor
inhibit
gtpase
activ
dynamin
specif
inhibitor
work
revers
therefor
endosom
pathway
restart
drug
remov
cultur
cell
prepar
well
plate
treat
dulbecco
modifi
eagl
medium
dmem
wako
contain
variou
concentr
inhibitor
min
cell
chill
ice
min
media
remov
cell
infect
ibav
hr
wash
pb
cell
incub
dmem
plu
inhibitor
min
media
replac
dmem
contain
fetal
bovin
serum
cell
incub
hr
cultur
supernat
collect
collect
supernat
subject
plaqu
assay
stain
crystal
violet
solut
crystal
violet
buffer
formalin
methanol
number
plaqu
count
analyz
statist
signific
inhibitor
concentr
group
mock
treat
group
statist
softwar
r
use
run
dunnet
test
figur
show
number
infecti
ibav
supernat
cell
treat
baf
cpz
dynasor
inhibitor
shown
decreas
viru
titer
concentr
elev
signific
decreas
observ
baf
concentr
higher
nm
nm
nm
time
effect
inhibitor
viabil
test
cell
well
multiwel
plate
treat
media
contain
variou
concentr
inhibitor
hr
without
ibav
infect
hr
incub
number
viabl
cell
quantifi
use
aqueou
one
solut
reagent
promega
madison
wi
usa
shown
fig
inhibitor
show
signific
effect
viabl
cell
number
result
indic
ibav
util
clathrindepend
endosom
pathway
infect
coincid
previou
research
bluetongu
viru
entri
confirm
effect
low
ph
viru
infect
purifi
ibav
incub
pb
sever
ph
five
min
infect
employ
lower
moi
protect
cell
sever
cpe
earli
time
point
achiev
multi
cycl
infect
dmem
without
fb
use
control
incub
signific
differ
control
test
group
analyz
dunnet
test
shown
fig
product
progeni
viru
significantli
suppress
ibav
treat
pb
compar
control
treatment
p
condit
give
impact
ibav
infect
p
valu
respect
ph
pbsibav
mix
solut
confirm
ph
test
paper
min
incub
data
shown
mani
envelop
virus
lose
infect
low
ph
treatment
util
endosom
acidif
trigger
activ
protein
respons
infect
result
obtain
studi
consist
observ
suggest
low
ph
treatment
caus
irrevers
chang
ibav
particl
lead
loss
infect
understand
mechan
loss
infect
viru
particl
collect
ultracentrifug
low
ph
treatment
western
blot
analysi
use
antisera
antiibav
antisera
perform
visual
fig
approxim
molecular
weight
kda
respect
case
btv
shown
form
outer
capsid
layer
play
import
role
initi
step
infect
protein
report
sialic
acid
bind
protein
implic
play
role
attach
target
cell
believ
work
protein
disturb
lipid
bilay
target
cell
shown
left
panel
fig
detect
viru
treat
pb
wherea
detect
viru
treat
pb
similarli
less
detect
viru
treat
pb
compar
viru
treat
pb
amount
seem
pb
pb
henc
suggest
amount
viral
core
sampl
result
obtain
implic
low
ph
treatment
remov
ibav
outer
capsid
protein
particl
initi
infect
test
low
ph
treatment
bypass
inhibitori
effect
endosom
inhibitor
treat
ibav
attach
cell
surfac
pb
pb
presenc
endosom
inhibitor
briefli
pretreat
inhibitor
min
cell
chill
ice
min
infect
ibav
hr
step
viru
get
intern
endocytosi
low
temperatur
attach
virus
treat
pb
pb
min
cell
treat
plu
inhibitor
min
hr
incub
viru
titer
supernat
determin
shown
fig
signific
differ
observ
viru
titer
pb
pb
baf
use
welch
ttest
cell
treat
inhibitor
differ
ph
buffer
made
differ
viral
titer
figur
show
viabil
seri
treatment
without
viru
infect
signific
differ
observ
welch
ttest
result
obtain
approach
confirm
usag
clathrindepend
endocytosi
pathway
orbiviru
support
previou
report
addit
prove
exposur
low
ph
environ
essenti
condit
initi
ibav
infect
presenc
baf
acidif
late
endosom
well
fusion
lysosom
impair
although
cell
surfac
virus
could
intern
posttreat
expos
low
ph
environ
presenc
baf
howev
virus
expos
low
ph
cell
surfac
intern
acquir
infect
could
start
infect
effect
baf
pb
fail
enhanc
ibav
infect
influenc
two
inhibitor
sinc
two
inhibitor
interrupt
endosom
pathway
begin
ibav
could
incorpor
posttreat
might
make
ibav
group
start
infect
time
result
viral
titer
sinc
could
deni
involv
proteas
addit
research
requir
reveal
entir
molecular
mechan
orbiviru
infect
import
low
ph
environ
ibav
activ
prove
studi
help
design
experiment
approach
studi
